Journal article

DNA methylation profiling enables subclassification of mucinous ovarian carcinoma and distinguishes it from extraovarian mucinous metastases.

Teodor G Calina, Elena Grafenhorst, Simon Schallenberg, Markus Möbs, Bjarne Daenekas, Alexandru A Sabo, BaoQing Chen, Ines Koch, Tobias Janik, Michael Churchman, Charlie Gourley, Elizabeth L Christie, Catalin Vasilescu, Vlad Herlea, Wolfgang D Schmitt, Nicolae Leopold, Florian Heitz, Angelina Vlaski, Yuri Tolkach, Felix Bremmer Show all

Cell Rep Med | Elsevier BV | Published : 2026

Open access

Abstract

Mucinous ovarian carcinoma (MOC) is an epithelial ovarian cancer subtype that is frequently misclassified as extraovarian mucinous metastasis (EOM) because of overlapping features. To address this diagnostic challenge, we perform genome-wide DNA methylation profiling of 58 MOCs, 38 EOMs, and 18 mucinous borderline ovarian tumors (mBOTs) collected from six institutions. Methylation analysis defines two mBOT groups, one epigenetically similar to normal ovary and one resembling MOC. Unsupervised clustering reveals two distinct MOC methylation subtypes with potential prognostic relevance in the internal cohort. Using these data together with 389 external profiles, we develop and validate a three..

View full abstract

University of Melbourne Researchers